Tolerability and Pharmacokinetics of BIIB 722 CL Drinking Solution and of BIIB 722 CL Filmcoated Tablet in Healthy Subjects
Clinical trial NCT02227030 · COMPLETED
Trial details
- NCT number
- NCT02227030
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2000-04-01
- Primary completion
- 2000-09-01
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.